Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 7817

The president also ordered a boost in the education of specialists in genetics and genome sequencing and the domestic production of necessary laboratory equipment, as well as tax cuts for biomedical research. Russia will also open world-class genome research centers which will, among their immediate goals, work on the development of treatments and vaccines for Covid-19.

The future database will be one of the tools that Russia hopes to use to assume a leading position in the biomedical industry. The government sees it as crucial for keeping the country competitive on the world stage going forward.

The Kurchatov Institute, which is best known for nuclear research, has been tasked with laying the foundation for the database, choosing the storage format and making tools for search and analysis. The institute has experience in the secure handling of large amounts of sensitive data and operates a number of data centers across Russia which are used for scientific collaboration projects.

Read more | >

The research described in this article has been published on a preprint server but has not yet been peer-reviewed by scientific or medical experts.

In hopes of developing a possible treatment for Covid-19, a team of MIT chemists has designed a drug candidate that they believe may block coronaviruses’ ability to enter human cells. The potential drug is a short protein fragment, or peptide, that mimics a protein found on the surface of human cells.

The researchers have shown that their new peptide can bind to the viral protein that coronaviruses use to enter human cells, potentially disarming it.

MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.

Continue reading “An experimental peptide could block Covid-19” | >

IBM will no longer offer general purpose facial recognition or analysis software, IBM CEO Arvind Krishna said in a letter to Congress today. The company will also no longer develop or research the technology, IBM tells The Verge. Krishna addressed the letter to Sens. Cory Booker (D-NJ) and Kamala Harris (D-CA) and Reps. Karen Bass (D-CA), Hakeem Jeffries (D-NY), and Jerrold Nadler (D-NY).

“IBM firmly opposes and will not condone uses of any [facial recognition] technology, including facial recognition technology offered by other vendors, for mass surveillance, racial profiling, violations of basic human rights and freedoms, or any purpose which is not consistent with our values and Principles of Trust and Transparency,” Krishna said in the letter. “We believe now is the time to begin a national dialogue on whether and how facial recognition technology should be employed by domestic law enforcement agencies.”

Read more | >

“Properties that have never been found in nature”

New claims that the novel coronavirus SARS-CoV-2 was engineered have been dismissed by scientific and intelligence experts.

The authors of a British-Norwegian vaccine study—accepted by the Quarterly Review of Biophysics—claim that the coronavirus’s spike protein contains sequences that appear to be artificially inserted.

In their paper, the Norwegian scientist Birger Sørensen and British oncologist Angus Dalgleish claim to have identified “inserted sections placed on the SARS-CoV-2 spike surface” that explains how the virus interacts with cells in the human body. Virologists, however, note that similar sections appear naturally in other viruses.

Continue reading “Controversial Coronavirus Lab Origin Claims Dismissed By Experts” | >

There is great promise in 2020 that we might be able to make our bodies young without having to explicitly repair molecular damage, but just by changing the signaling environment.

Do we need to add signals that say “young” or remove signals that say “old”?

Does infusion of biochemical signals from young blood plasma rejuvenate tissues of an old animal? Or are there dissolved signal proteins in old animals that must be removed?

Read more | >